The dopamine and glutamate theories of schizophrenia: A short review

Current Anaesthesia and Critical Care

Volumn 20, Issue 5-6, 2009, Pages 240-241

  Bradford, A ^a  

^a DURHAM UNIVERSITY   (United Kingdom)

Author keywords

ACC; Dopamine; Glutamate; Schizophrenia

Indexed keywords

BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; DIZOCILPINE; DOPAMINE; DOPAMINE 2 RECEPTOR BLOCKING AGENT; GLUTAMIC ACID; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PHENCYCLIDINE;

ARTICLE; BEHAVIOR DISORDER; BRAIN DISEASE; DISEASE COURSE; DOPAMINERGIC SYSTEM; DRUG EFFICACY; EMOTIONAL DISORDER; ENVIRONMENTAL FACTOR; EXTRAPYRAMIDAL SYMPTOM; GENETIC DISORDER; GENETIC RISK; HALLUCINATION; HUMAN; MESENCEPHALON; NEGATIVE SYNDROME; NEUROPSYCHOLOGY; NEUROTRANSMISSION; NONHUMAN; PARANOIA; PATHOGENESIS; PATHOPHYSIOLOGY; POSITIVE SYNDROME; PRIORITY JOURNAL; PROTEIN DEFECT; PSYCHOSIS; RISK ASSESSMENT; RISK FACTOR; SCHIZOPHRENIA; SPEECH DISORDER; THOUGHT DISORDER;

EID: 69649087304     PISSN: 09537112     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cacc.2009.07.008     Document Type: Article

References (14)

1. Harrison P.J. Schizophrenia: a disorder of neurodevelopment?. Current Opinion in Neurobiology 7 (1997) 285-289
2. Hempel A., Hempel E., Schonknecht P., Stippich C., and Schroder J. Impairment in basal limbic function in schizophrenia during affect recognition. Psychiatry Research 122 (2003) 115-124
3. Carter C.S., MacDonald III A.W., Ross L.L., and Stenger V.A. Anterior cingulate cortex activity and impaired self-monitoring of performance in patients with schizophrenia: an event-related fMRI study. American Journal of Psychiatry 158 (2001) 1423-1428
4. Salgado-Pineda P., Baeza I., Perez-Gomez M., Vendrell P., Junque C., Bargallo H., et al. Sustained attention impairment correlates to gray matter decreases in first episode neuroleptic-naive schizophrenic patients. Neuroimage 19 (2003) 365-375
5. Angrist B., Sathananthan G., Wilk S., and Gershon S. Amphetamine psychosis: behavioural and biochemical aspects. Journal of Psychiatry Research 11 (1974) 13-23
6. Kim J.S., Kornhuber H.H., Schmid-Burgk W., and Holzmuller B. Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia. Neuroscience Letters 20 (1980) 379-382
7. Alder C.M., Malhotra A.K., Elman I., Goldberg T., Egan M., Pickar D., et al. Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia. American Journal of Psychiatry 156 (1999) 1646-1649
8. Jarvitt D.C., and Zukin S.R. Recent advances in the phencyclidine model of schizophrenia. American Journal of Psychiatry 148 (1991) 1301-1308
9. Selemon L.D., and Goldman-Rakic P.S. The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biological Psychiatry 45 (1999) 17-25
10. Huntley G.W., Vickers J.C., and Morrison J.H. Cellular and synaptic localization of NMDA and non-NMDA receptor subunits in neocortex: organizational features related to cortical circuitry, function and disease. Trends in Neuroscience 17 (1994) 536-543
11. Weinberger D. A connectionist approach to the prefrontal cortex. Journal of Neuropsychiatry 5 (1993) 241-253
12. Zavitsanou K., Ward P.B., and Huang X.-F. Selective alterations in ionotropic glutamate receptors in the anterior cingulate cortex in schizophenia. Neuropsychopharmacology 27 (2002) 826-833
13. Kotter H. Postsynaptic integration of glutamatergic and dopaminergic signals in the striatum. Progression in Neurobiology 44 (1994) 163-196
14. Lewis D.A., and Liebermann J.A. Catching up on schizophrenia: natural history and neurobiology. Neuron 28 (2000) 325-334